Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Is a Beat Likely for Edwards Lifesciences (EW) in Q2 Earnings?
12:07pm, Monday, 15'th Jul 2024
Edwards Lifesciences' (EW) TMTT segment's PASCAL platform is likely to have maintained strong growth momentum in the second quarter globally, backed by its portfolio of differentiated therapies.
HOLX or EW: Which Is the Better Value Stock Right Now?
12:41pm, Friday, 12'th Jul 2024
Investors looking for stocks in the Medical - Instruments sector might want to consider either Hologic (HOLX) or Edwards Lifesciences (EW). But which of these two stocks offers value investors a bette
Final Trades: Edwards Lifesciences, First Citizens, UnitedHealth and iShares US Real Estate ETF
01:40pm, Wednesday, 10'th Jul 2024
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: Edwards Lifesciences, American Tower & TransDigm
01:58pm, Wednesday, 26'th Jun 2024
The Investment Committee discuss their top stocks to watch for the second half.
HOLX vs. EW: Which Stock Is the Better Value Option?
12:45pm, Wednesday, 26'th Jun 2024
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Hologic (HOLX) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a
East West Petroleum Announces Proposed Return of Capital
07:00am, Wednesday, 19'th Jun 2024
Vancouver, British Columbia--(Newsfile Corp. - June 19, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") announces that the Board of directors has determined that its in the
HOLX vs. EW: Which Stock Should Value Investors Buy Now?
12:45pm, Monday, 10'th Jun 2024
Investors looking for stocks in the Medical - Instruments sector might want to consider either Hologic (HOLX) or Edwards Lifesciences (EW). But which of these two stocks offers value investors a bette
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
11:45am, Wednesday, 05'th Jun 2024
NEW YORK--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TA
Becton Dickinson Buys Critical Care Unit From Edwards Lifesciences for $4.2B
04:45pm, Monday, 03'rd Jun 2024
Shares of Becton Dickinson (BDX) advanced close to 3% Monday as the maker of syringes and other medical devices announced it was buying the Critical Care product unit of Edwards Lifesciences (EW) for
Calls of the Day: Costco, Edwards Lifesciences, Citigroup, American Express & Fedex
01:53pm, Monday, 03'rd Jun 2024
The Investment Committee give you their take on the latest Calls of the Day.
Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash
08:25am, Monday, 03'rd Jun 2024
The buyer intends to fund deal with a combination of $1 billion in cash and $3.2 billion of new debt in a transaction that is one of its largest of many.
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln
07:43am, Monday, 03'rd Jun 2024
Edwards Lifesciences on Monday said it has agreed to sell its Critical Care products unit to Becton Dickinson in an all-cash transaction valued at $4.2 billion.
Edwards Lifesciences to sell its critical care product group for $4.2 billion to Becton Dickinson
06:40am, Monday, 03'rd Jun 2024
Shares of Edwards Lifesciences Corp. EW, -1.14% rallied 3% in premarket trading Monday, after the company announced an agreement to sell its critical care product group to Becton Dickinson & Co. BDX,
Edwards Lifesciences to Sell Critical Care to BD
06:30am, Monday, 03'rd Jun 2024
IRVINE, CA--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (N
Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to BD revenue growth, adjusted gross margin, adjusted operating margin and adjusted EPS Expands
